๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for System Lupus Erythematosus

Biomarkers in Inflammatory Rheumatic Diseases Diagnosis NCT06778343n/a1 site๐Ÿ“ Lisbon Universidade Nova de Lisboa Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. NCT06581562Phase 11 site๐Ÿ“ Plantation IRIS Research and Development, LLC ยท Tests: AB-101, Rituximab, Cyclophosphamide, Fludarabine The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study NCT05538208Phase 219 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Children's Hospital Medical Center, Cincinnati ยท Tests: Mycophenolate Mofetil, Mycophenolate Mofetil Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment NCT07102030n/a1 site๐Ÿ“ Stockholm Region Stockholm A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus NCT07444307Phase 13 sites๐Ÿ“ Hefei๐Ÿ“ Wuhan๐Ÿ“ Beijing Hangzhou Qihan Biotech Co., Ltd. ยท Tests: QT-019B Cell Injection An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease NCT07077486Phase 41 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Methylprednisolone (Corticosteroid), Immunosuppressant other than CYC, Telitacicept Freeze-dried powder Injection 80mg,โ€ฆ A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus NCT07405970Phase 31 site๐Ÿ“ Beijing Beijing Mabworks Biotech Co., Ltd. ยท Tests: MIL62, Placebo Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE NCT07233642Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: CD19 CAR-T cells Transcutaneous Vagus Nerve Stimulation in SLE NCT06987565Phase 21 site๐Ÿ“ Manhasset Northwell Health ยท Tests: Active vagus nerve stimulation, Sham vagus nerve stimulation A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites๐Ÿ“ Little Rock๐Ÿ“ Tustin๐Ÿ“ Gainesville Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT07052565NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases NCT07470151NA1 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: EVM18001 Injection Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases NCT07558850NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: anti-CD19/BCMA-UCAR-T cells Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD19- BCMA CAR-T cells Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site๐Ÿ“ Palo Alto Alice Bertaina ยท Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell Systemic Lupus Erythematosus in Gullah Health NCT00756769n/a1 site๐Ÿ“ Charleston Medical University of South Carolina Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone NCT07760480Phase 41 site๐Ÿ“ Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Kidney Biopsy, Voclosporin (LUPKYNIS), Blood, feces and urine sample collection, LupusPRO questionnaire, Mycophenolate โ€ฆ AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity NCT07043153n/a1 site๐Ÿ“ Sohag Sohag University ยท Tests: Albumin to globulin ratio and prognostic nutritional index model The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis NCT02954939NA1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: MMF-MMF, CTX-AZA NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631Phase 11 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: NK 010 or NK042, Rituximab Dose Response of Exercise for Arthritis Management NCT06880653NA1 site๐Ÿ“ Columbia University of South Carolina ยท Tests: DREAM Adaptive Intervention Argentinian Prospective Registry of Patients With Lupus NCT05470569n/a1 site๐Ÿ“ La Plata Sociedad Argentina de Reumatologia Deciphering the Genetic Architecture of Autoimmune Diseases NCT06948110n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Lima National Human Genome Research Institute (NHGRI) Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases NCT06685042Phase 1, Phase 21 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: CAR T cell Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients NCT06394063NA1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Telitacicept, Placebo CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C A Clinical Study of CD19 Universal CAR-ฮณฮดT Cells in Active Systemic Lupus Erythematosus NCT06106893Phase 1, Phase 21 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: CD19 Universal CAR-ฮณฮด T Cells An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy